Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Cervical Neoplasms × Everolimus × Clear all

Sponsor

Conditions

Breast Neoplasms 34 Carcinoma, Renal Cell 29 Neoplasms 17 Kidney Neoplasms 15 Neuroendocrine Tumors 13 Neoplasm Metastasis 12 Tuberous Sclerosis 8 Prostatic Neoplasms 8 Carcinoma 8 Lymphoma, Mantle-Cell 7 Hodgkin Disease 7 Waldenstrom Macroglobulinemia 6 Recurrence 6 Lymphoma, Large B-Cell, Diffuse 6 Head and Neck Neoplasms 6 Glioma 6 Triple Negative Breast Neoplasms 5 Ovarian Neoplasms 5 Lymphoma 5 Glioblastoma 5 Colorectal Neoplasms 5 Carcinoma, Neuroendocrine 5 Brain Neoplasms 5 Astrocytoma 5 Sezary Syndrome 4 Sarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Mycosis Fungoides 4 Melanoma 4

Interventions

Cisplatin 28 human papillomavirus vaccine, L1 type 16, 18 16 Brachytherapy 13 Bevacizumab 11 Paclitaxel 10 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 10 Platinum 9 1,2-diaminocyclohexaneplatinum II citrate 9 Topotecan 8 Radiation 8 Papillomavirus Vaccines 8 Radiotherapy, Intensity-Modulated 7 pembrolizumab 6 Cyclophosphamide 6 tisotumab vedotin 5 fludarabine phosphate 5 fludarabine 5 aldesleukin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Gemcitabine 5 Fluorodeoxyglucose F18 5 Carboplatin 5 atezolizumab 4 Vaccines, Synthetic 4 Taxes 4 Nivolumab 4 Colposcopy 4 Tobacco Use Cessation Devices 3 Surveys and Questionnaires 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡